Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
Condition: Methamphetamine Abuse Intervention: Behavioral: Affect Methamphetamine Treatment Program Sponsor: Affect Therapeutics, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2022 Category: Research Source Type: clinical trials
